Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058612) titled 'Qualitative Interview Study with Physicians Involved in Diagnosis and Management of IgA Nephropathy' on July 28.
Study Type:
Observational
Primary Sponsor:
Institute - Viatris Pharmaceuticals Japan G.K.
Condition:
Condition - IgA nephropathy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Interviews will be conducted with nephrologists and internists working in hospitals with 200 or more beds, excluding university hospitals and clinics that diagnose and treat patients with IgA nephropathy, and urologists working in university hospitals and hospitals with 200 beds ...